JPRN-UMIN000004921已完成1 期
Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancer - Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) with active double cancer 2) with severe complications (congested heart failure, coronary insufficiency, myocardial infarction, angina pectoris or abnormal cardiac rhythm which need to treat, history of cerebrovascular accident, hemorrhagic gastrointestinal ulceration, uncontrolled diabetes, renal failure, active hepatitis, liver cirrhosis) 3) possible infection associated with clinical symptoms such as fever 4) uncontrolled pleural effusion, pericardial effusion 5) pregnant or nursing women or women who like be pregnant 6) with pulmonary fibrosis or pneumonitis 7) with history of mental disorder or treating it at the moment 8) with history of severe allergy 9) with severe allergy to TS-1 and Lapatinib 10) patients receiving Flucytosine 11) doctor's decision not to be registered to this study
研究者
相似试验
已完成
不适用
Phase I study of nedaplatin and S-1 in patients with advanced or relapsed squamous cell lung cancerSquamous cell lung cancerJPRN-UMIN000036387Kagawa University9
招募中
1 期
Phase I/II trial of Nedaplatin/S-1 combination followed by maintenance S-1 therapy in advanced Squamous Cell Lung CancerJPRN-UMIN000009399Department of Medical Oncology, Kinki University Faculty of Medicine25
进行中（未招募）
不适用
Phase I/II study of Lapatinib in combination with Capecitabine and Vinorelbine for the second-line treatment of patients with refractory locally recurrent or metastatic breast cancer with ErbB2 overexpressioPatients with HER2 positive metastatic or locally recurrent adenocarcinoma of the breastMedDRA version: 14.1Level: LLTClassification code 10006174Term: Breast adenocarcinoma recurrentSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10065348Term: Breast adenocarcinoma metastaticSystem Organ Class: 100000004864EUCTR2008-000528-22-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA
招募中
1 期
Phase I trial of S-1 with Lapatinb for metastatic breast cancermetastatic breast cancerJPRN-UMIN000003583St. Luke's International Hospital18
尚未招募
1 期
Phase I/II Trial of S-1 and Nedaplatin with concurrent radiotherapy in locally advanced mesopharynx, hypopharynx cancerMesopharyngeal cancer Hypopharyngeal CancerJPRN-UMIN000003889Kitasato University School of Medicine43